In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Defining a clopidogrel response cut-off value using Light Transmission Aggregometry prior to Pipeline embolization of unruptured intracranial aneurysms

    Final Number:
    184

    Authors:
    N. Adeeb MD; R. Gupta BS; A. Schneider; M. Leadon; A. Enriquez-Marulanda; C. J. Griessenauer MD; M. Salem; A. Alturki; P. G. R. Schmalz MD; C. S. Ogilvy MD; A. J. Thomas MD; J. M. Moore B.Med.Sci (hon), MD, PhD

    Study Design:
    Other

    Subject Category:
    Aneurysm/Subarachnoid Hemorrhage

    Meeting: AANS/CNS Cerebrovascular Section 2018 Annual Meeting

    Introduction: Dual antiplatelet therapy is the current standard of care to mitigate the risk of thromboembolic complications following intracranial aneurysm Pipeline Embolization Device (PED) placement. The choice of appropriate antiplatelet therapy is usually guided by platelet function testing such as light transmission aggregometry (LTA). In this study, we aimed to define the optimal threshold LTA value for clopidogrel responsiveness.

    Methods: A prospectively maintained database at an academic neurosurgical center in the United States was retrospectively analyzed from 2014 to 2017 to identify patients with unruptured intracranial aneurysms treated with the PED. Clinical and radiographic data were analyzed with an emphasis on identifying thromboembolic complications in the context of platelet function testing performed by LTA.

    Results: A total of 95 procedures (median age: 61 years) were performed for PED placement to treat 110 unruptured intracranial aneurysms. Thromboembolic complications were encountered in 4 (4.2%) of these patients. After stratifying the complication rate based on the maximal extent of platelet aggregation following administration of an exogenous platelet agonist, a marked increase in thromboembolic events was observed in patients with LTA values greater than 50%. When LTA was dichotomized based on this value, patients with an LTA value less than 50% had a thromboembolic complication rate of 1.3%, compared to 20% for those with LTA values over 50% .

    Conclusions: Currently, there is no accepted standard cutoff LTA value for determining the clopidogrel response in neuroendovascular procedures. We observed the greatest increase in the rate of thromboembolic complications with LTA values of over 50%.

    Patient Care: Define the ideal cut off value for light transmission aggregometry in neurointervention.

    Learning Objectives: By the conclusion of this session, participants should be able to define the role of light transmission aggregometry for platelet function testing prior to Pipeline embolization.

    References:

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy